Alta Growth Capital and Fondo de Fondos aquire Mexican API Producer Interquim
Mexico City, Mexico, December 13, 2021 – Alta Growth Capital (“AGC”) announced today that they have led the acquisition of 100% of the outstanding shares of Interquim, a leading active pharmaceutical ingredients (“APIs”) producer in Mexico. Fondo de Fondos participated as AGC’s co-investor to complete the ticket.
Headquartered in Mexico State, the Company is internationally recognized, particularly in the production of Vitamin B12 derivatives and small-scale APIs and is well-positioned to benefit from the trend in the industry to diversify supply chains, including geographically. Alta will work with the Company to continue its international growth in niche pharmaceutical ingredients, as well as continue serving its existing client base with high quality APIs.
Javier Garcia Teruel Avila, Managing Director of Alta Growth Capital, highlighted, “Interquim has transformed itself into a leading Mexican producer of niche API’s for clients worldwide. The Company’s high-quality standards, reliability, key regulator certifications, and robust R&D capabilities make it an ideal partner for pharmaceutical clients and will support its significant growth perspective.”
Stefano Salmieri, CEO of Interquim, added: “This is a strategically important step in the evolution of the Company. Alta has the track record of working with experienced management teams to institutionalize companies and create value. This partnership with a strong financial investor gives Interquim and its employees the opportunity to continue growing the business and to take full advantage of the market’s potential. I am confident that Alta, together with the current management team, will succeed in implementing the Company’s strategy, aimed at providing superior products and services to its pharmaceutical customers worldwide while consolidating Interquim’s position as a highly reliable manufacturer.”
Interquim was advised by Venser (Venture Advisory Services).
Read more at LAVCA
About Interquim
Established in 1983 in Mexico to contribute to the development of the pharmaceutical industry, Interquim is one of the few API producers in Mexico and Latin America. Interquim is one of the world’s leading independent players in the production of Vitamin B12 derivatives, as well as niche products within the molecules market. Currently, the Company’s team has +120 highly qualified employees that service +100 clients in 31 countries. Its Good Manufacturing Practices (GMPs) have been certified by several health authorities, both national and international. The Company is committed to innovation and high-quality service standards.
About Alta Growth Capital
Alta Growth Capital manages private equity funds focused on growth equity and buyouts in middle-market companies in Mexico and Latin America. AGC has been operating since 2007 in Latin America and is now investing out of its third fund.